Non-vascular Stents Market Size & Growth Forecast 2026–2035, By Segments (End Use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Non-vascular Stents Market size stood at USD 1.76 Billion in 2025 and is predicted to grow at a 4.9% CAGR from 2026 to 2035, attaining USD 2.84 Billion by 2035. The industry revenue for 2026 is estimated at USD 1.84 billion.
Get more details on this report
Request Free Sample ReportNon-vascular Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to high procedural volumes, mature hospital infrastructure, and strong clinical familiarity with minimally invasive stenting across gastrointestinal and urological applications.
- Asia Pacific grows at 5.59% CAGR driven by expanding access to interventional care and rising adoption of minimally invasive procedures across high-volume clinical settings.
Segment Momentum
- Hospitals lead the market because they manage complex stent procedures requiring multidisciplinary care, advanced imaging, and post-procedure monitoring, making them the primary setting for higher-acuity non-vascular stent interventions.
- Esophageal Stents are growing fastest as demand increases for minimally invasive procedures that restore swallowing function and relieve obstruction through targeted, procedure-specific stent solutions.
Market Expansion Drivers
- Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand.
- Expanding clinical trials and surgical volumes supporting procedural adoption of stents.
- Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Major players in the non-vascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), CONMED Corporation (United States), ELLA-CS, s.r.o. (Czech Republic), Glaukos Corporation (United States), Hobbs Medical, Inc. (United States), Merit Medical Systems, Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
An aging patient base is steadily increasing the incidence of conditions such as biliary obstruction, urinary strictures, gastrointestinal narrowing, and other chronic disorders that often require mechanical lumen support rather than open surgical correction. In the non-vascular stents market, This trends demand toward devices that can provide symptom relief, restore drainage, and reduce procedure burden for patients who may not tolerate more invasive interventions well. Chronic disease management is also becoming more longitudinal, which reinforces repeat procedural need, follow-up interventions, and physician familiarity with stent-based treatment pathways, contributing to market size growth through routine use in gastroenterology, urology, and related specialties.
Expanding clinical trials and surgical volumes supporting procedural adoption of stents
As clinical studies continue to evaluate stent designs, materials, and placement strategies, physicians gain stronger procedural confidence and clearer evidence on where non-vascular stents fit into treatment algorithms. That evidence translates into more standardized use in hospitals and specialty centers, especially as rising surgical and interventional volumes expose more patients to stent-eligible conditions during routine care. For the non-vascular stents market, the practical effect is broader procedural adoption as clinicians incorporate stenting earlier or more consistently in obstruction management, while providers increase inventory and training around devices that align with growing case throughput.
Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care
Improvements in endoscopic visualization, delivery systems, and placement precision are making stent procedures less disruptive and easier to perform in ambulatory and short-stay settings. This is influencing market adoption in the non-vascular stents market by lowering the operational barriers associated with inpatient surgery, shortening recovery expectations, and making stent placement a more practical option for both providers and patients. As outpatient care models expand, device selection increasingly favors stents compatible with efficient endoscopic workflows, aiding market expansion through higher procedural accessibility and wider use in routine non-vascular obstruction treatment.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising geriatric population and chronic disease prevalence increasing non-vascular stent demand | 2.00% | High | North America, Europe | High | Near Term |
| Expanding clinical trials and surgical volumes supporting procedural adoption of stents | 1.80% | High | North America, Europe | Medium | Mid Term |
| Advancements in minimally invasive endoscopic procedures expanding stent utilization in outpatient care | 1.50% | High | Asia Pacific, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the largest regional market share in 2025 for the non-vascular stents market, backed by established procedural volumes, broad availability of interventional treatment settings, and consistent use of stents across gastrointestinal, urological, and other non-vascular applications. The region’s leadership is aided by mature hospital infrastructure and clinical familiarity with minimally invasive stenting procedures, which helps sustain steady device utilization in routine care pathways and supports continued demand across specialty practices.
Asia Pacific is projected to expand at a 5.59% CAGR over the forecast period in the non-vascular stents market, driven by rising adoption of interventional procedures as access to specialized care broadens across the region. Growth is being fueled by the increasing use of minimally invasive treatment approaches in high-volume clinical settings, where expanding healthcare capacity and greater procedural uptake are translating into stronger demand for non-vascular stents in everyday practice.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical ApplicationsGermany’s non-vascular stents market reflects strong adoption of advanced medical solutions within specialized hospital environments. Providers focus on durable devices, procedural accuracy, and innovations that support complex interventions while maintaining high standards for patient care and device performance.
France 🇫🇷
Specialized Treatment SolutionsFrance’s non-vascular stents market centers on advanced clinical applications requiring effective and reliable implantable devices. Healthcare providers prioritize solutions that support minimally invasive procedures, enhance therapeutic outcomes, and integrate with specialized care pathways across hospitals and clinics.
Italy 🇮🇹
Hospital Procedure SupportItaly’s non-vascular stents market is driven by healthcare demand for dependable devices used in complex therapeutic procedures. Hospitals focus on solutions that improve intervention quality, simplify clinical workflows, and provide effective support for gastrointestinal and airway-related treatments.
Japan 🇯🇵
Aging Care TechnologiesJapan’s non-vascular stents market is influenced by increasing demand for minimally invasive treatment approaches in digestive and respiratory care. Medical institutions emphasize dependable devices that support complex procedures, improve patient comfort, and align with evolving healthcare needs.
South Korea 🇰🇷
Procedure Innovation FocusSouth Korea’s non-vascular stents market is shaped by expanding adoption of advanced endoscopic and interventional procedures. Hospitals seek innovative stent technologies that improve treatment flexibility, support physician efficiency, and address growing demand for specialized medical interventions.
United States 🇺🇸
Advanced Medical DevicesThe U.S. non-vascular stents market is supported by demand for minimally invasive interventions across gastrointestinal, airway, and urological procedures. Healthcare providers prioritize reliable stent designs, improved patient outcomes, and technologies that enhance procedural efficiency in specialized clinical settings.
Segment Leadership and Growth Trends
Non-vascular Stents Market Share (%), End Use, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportHospitals held the largest share of the non-vascular stents market in 2025, supported by their central role in handling complex stent placement procedures that require multidisciplinary care, advanced imaging access, and post-procedure monitoring. Their leadership in share is sustained by established referral pathways and the ability to manage a broader range of patient conditions, which keeps hospitals the primary setting for non-vascular stents use across higher-acuity cases.
Ambulatory Care Centers (ACS) are the fastest-growing end-use segment in the non-vascular stents market as procedural volumes increasingly shift toward settings that can deliver efficient intervention for suitable patients without the infrastructure demands of full-scale hospitals. Their momentum is being supported by the practical move toward streamlined outpatient care, especially where non-vascular stents placement can be performed with shorter stays, faster scheduling, and lower procedural burden relative to traditional inpatient environments.
Type Segment Analysis: Gastrointestinal Stents (Largest Segment) vs Esophageal Stents (Fastest-Growing Segment)
Gastrointestinal Stents accounted for the largest share of the non-vascular stents market in 2025, reflecting their broad clinical use across gastrointestinal tract obstructions and related conditions that require minimally invasive luminal support. This segment’s leadership in share is maintained by the wider procedural base associated with gastrointestinal applications, which gives it a more established utilization pattern than narrower stent categories within the non-vascular stents market.
Esophageal Stents represent the fastest-growing type segment in the non-vascular stents market, driven by rising adoption in cases where targeted intervention is needed to restore swallowing function and relieve obstruction with less invasive treatment. Their growth is outpacing alternatives because esophageal applications often require focused, procedure-specific stent solutions, creating stronger momentum for this category as treatment pathways continue to favor interventional management over more burdensome approaches.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics | Hospitals | Ambulatory Care Centers (ACS) |
| Type | Gastrointestinal Stents, Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents, Pulmonary (Airway) Stents, Silicone Airway, Metallic Airway, Urological Stents, Others | Gastrointestinal Stents | Esophageal Stents |
Competitive Landscape and Market Positioning
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Becton Dickinson and Company (United States)
4. Cook Medical LLC (United States)
5. CONMED Corporation (United States)
6. ELLA-CS s.r.o. (Czech Republic)
7. Glaukos Corporation (United States)
8. Hobbs Medical Inc. (United States)
9. Merit Medical Systems Inc. (United States)
The non-vascular stents market is advancing through innovations in minimally invasive device design and material engineering. Frequent introduction of improved stent solutions is enhancing procedural outcomes and patient recovery. Collaborative efforts with healthcare systems are supporting broader adoption of advanced stent technologies.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cook Medical | Mar-24 | Cook Medical and Getinge signed a commercial distribution agreement for the iCast covered stent system in the United States. The collaboration aims to expand patient access to the device across relevant clinical settings for vascular and endovascular treatment applications. |
| BD (Becton, Dickinson and Company) | Mar-24 | BD initiated first patient enrollment in its AGILITY investigational device exemption study evaluating the BD Vascular Covered Stent for peripheral arterial disease treatment. The study assesses safety and effectiveness to support clinical validation and potential regulatory advancement. |
| Cook Medical | Mar-24 | Cook Medical and Getinge entered a commercial distribution agreement for the iCast covered stent system in March 2024. The partnership is intended to expand access to the device across the U.S. market, improving availability for patients requiring endovascular treatment options and strengthening commercialization pathways for covered stent technologies. |
| Becton, Dickinson and Company | Mar-24 | Becton, Dickinson and Company initiated first patient enrollment in the AGILITY investigational device exemption study in March 2024. The clinical trial evaluates the BD Vascular Covered Stent for treatment of peripheral arterial disease, supporting regulatory validation and clinical evidence generation for next-generation endovascular stent technologies. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Non-vascular Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Non-vascular Stents Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the non-vascular stents market?
How is the non-vascular stents industry size expected to evolve during the forecast period?
How are demographic and chronic disease trends influencing demand in the non-vascular stents market?
How are minimally invasive procedures reshaping stent adoption in the non-vascular stents market?
Why do hospitals lead the non-vascular stents market?
Why are Esophageal Stents the fastest-growing type segment?
Why does North America lead the non-vascular stents market?
What is driving growth in the Asia Pacific non-vascular stents market?
Which companies are driving growth in the non-vascular stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization